Recent advances in the design of iron chelators against oxidative damage.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Mini-Reviews in Medical Chemistry

• Publication date

  2001-08-31

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.2174/1389557013406846PMID 12369970
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• H2 O2 -Dependent Fe-Catalyzed Oxidations: Control of the Active Species.

  2001cited by this paper
• Improving the oral bioavailability of the iron chelator HBED by breaking the symmetry of the intramolecular H-bond network.

  2000cited by this paper
• The role of metals in neurodegenerative diseases.

  2000cited by this paper
• Protection against oxidative damage by iron chelators: effect of lipophilic analogues and prodrugs of N,N'-bis(3,4,5-trimethoxybenzyl)ethylenediamine- N,N'-diacetic acid (OR10141).

  2000cited by this paper
• Synthesis, physicochemical characterization, and biological evaluation of 2-(1'-hydroxyalkyl)-3-hydroxypyridin-4-ones: novel iron chelators with enhanced pFe(3+) values.

  1999cited by this paper
• The mechanism of "Fenton-like" reactions and their importance for biological systems. A biologist's view.

  1999cited by this paper
• Protection of U937 cells against oxidative injury by a novel series of iron chelators.

  1998cited by this paper
• Synthesis, physicochemical properties, and evaluation of N-substituted-2-alkyl-3-hydroxy-4(1H)-pyridinones.

  1998cited by this paper
• In Vitro Studies of Ferritin Iron Release and Neurotoxicity

  1998cited by this paper
• Modulation of transferrin receptor expression by dexrazoxane (ICRF-187) via activation of iron regulatory protein.

  1997cited by this paper
• The potential role of iron chelators in the treatment of Parkinson's disease and related neurological disorders.

  1997cited by this paper
• N,N'-bis-(3,4,5-trimethoxybenzyl) ethylenediamine N,N'-diacetic acid as a new iron chelator with potential medicinal applications against oxidative stress.

  1996cited by this paper
• Brain iron in the ferrocene-loaded rat: its chelation and influence on dopamine metabolism.

  1995cited by this paper
• N,N'-bis-dibenzyl ethylenediaminediacetic acid (DBED): a site-specific hydroxyl radical scavenger acting as an "oxidative stress activatable" iron chelator in vitro.

  1995cited by this paper
• Heme Degradation in the Presence of Glutathione

  1995cited by this paper
• Superoxide Radical and Iron Modulate Aconitase Activity in Mammalian Cells (*)

  1995cited by this paper
• Doxorubicin reduces the iron(III) complexes of the hydrolysis products of the antioxidant cardioprotective agent dexrazoxane (ICRF-187) and produces hydroxyl radicals.

  1995cited by this paper
• An orally active iron chelator.

  1995cited by this paper
• Iron-Chelating Agents in Non-Iron Overload Conditions

  1994cited by this paper
• The action of nine chelators on iron-dependent radical damage.

  1994cited by this paper
• Altered Brain Metabolism of Iron as a Cause of Neurodegenerative Diseases?

  1994cited by this paper
• Inhibition of catechol-O-methyltransferase (COMT) as well as tyrosine and tryptophan hydroxylase by the orally active iron chelator, 1,2-dimethyl-3-hydroxypyridin-4-one (L1, CP20), in rat brain in vivo.

  1993cited by this paper
• Iron: metabolism, toxicity and therapy.

  1993cited by this paper
• Regulating the fate of mRNA: the control of cellular iron metabolism.

  1993cited by this paper
• The hydrolysis product of ICRF-187 promotes iron-catalysed hydroxyl radical production via the Fenton reaction.

  1993cited by this paper
• The effects of 21-aminosteroids on the redox status of iron in solution.

  1993cited by this paper
• Skin inflammation: reactive oxygen species and the role of iron.

  1992cited by this paper
• Low molecular weight iron and the oxygen paradox in isolated rat hearts.

  1992cited by this paper
• Reactive Oxygen Species and the Central Nervous System

  1992cited by this paper
• Stimulation of lipid peroxidation and hydroxyl-radical generation by the contents of human atherosclerotic lesions.

  1992cited by this paper
• Iron chelators in medicine.

  1992cited by this paper
• The role of iron in oxygen-mediated toxicities.

  1992cited by this paper
• Ferritin as a source of iron for oxidative damage.

  1992cited by this paper
• Intramuscular desferrioxamine in patients with Alzheimer's disease.

  1991cited by this paper
• Evaluation of desferrithiocin and its synthetic analogues as orally effective iron chelators.

  1991cited by this paper
• Metal ion-catalyzed oxidation of proteins: biochemical mechanism and biological consequences.

  1990cited by this paper
• A pilot double-blind study of sodium-magnesium EDTA in peripheral vascular disease.

  1990cited by this paper
• Transition metals as catalysts of "autoxidation" reactions.

  1990cited by this paper
• Early treatment with deferoxamine limits myocardial ischemic/reperfusion injury.

  1989cited by this paper
• Prevention of postischemic cardiac injury by the orally active iron chelator 1,2-dimethyl-3-hydroxy-4-pyridone (L1) and the antioxidant (+)-cyanidanol-3.

  1989cited by this paper
• Redox reactions associated with iron release from mammalian ferritin.

  1989cited by this paper
• Colorimetric detection of the hydroxyl radical: comparison of the hydroxyl-radical-generating ability of various iron complexes.

  1988cited by this paper
• Novel 21-amino steroids as potent inhibitors of iron-dependent lipid peroxidation.

  1987cited by this paper
• The effect of desferrioxamine on transferrin receptors, the cell cycle and growth rates of human leukaemic cells.

  1986cited by this paper
• Superoxide-dependent and -independent mechanisms of iron mobilization from ferritin by xanthine oxidase. Implications for oxygen-free-radical-induced tissue destruction during ischaemia and inflammation.

  1986cited by this paper
• Reductive release of iron from ferritin by cation free radicals of paraquat and other bipyridyls.

  1986cited by this paper
• Brain iron delocalization and lipid peroxidation following cardiac arrest.

  1986cited by this paper
• Reduction of mammalian ferritin.

  1985cited by this paper
• Treatment of rheumatoid arthritis with desferrioxamine: relation between stores of iron before treatment and side effects.

  1985cited by this paper
• Iron-catalyzed hydroxyl radical formation. Stringent requirement for free iron coordination site.

  1984cited by this paper
• The mechanism of iron release from ferritin as related to its biological properties.

  1955cited by this paper

• Examination of diverse iron-chelating agents for the protection of differentiated PC12 cells against oxidative injury induced by 6-hydroxydopamine and dopamine

  2022cites this paper
• Recent Advances in Hydrogen Peroxide Responsive Organoborons for Biological and Biomedical Applications

  2021cites this paper
• Cardioprotective Potential of Iron Chelators and Prochelators.

  2019cites this paper
• Catechol thioethers with physiologically active fragments: Electrochemistry, antioxidant and cryoprotective activities.

  2019cites this paper
• Heavy metal toxicity: An update of chelating therapeutic strategies.

  2019cites this paper
• The iron pro-chelator BHAPI attenuates glutamate-induced oxidative stress via Wnt-β/catenin pathway in HT22 cells.

  2018cites this paper
• Structure-Activity Relationships of Nitro-Substituted Aroylhydrazone Iron Chelators with Antioxidant and Antiproliferative Activities.

  2018cites this paper
• 2,6-Dihydroxybenzaldehyde Analogues of the Iron Chelator Salicylaldehyde Isonicotinoyl Hydrazone: Increased Hydrolytic Stability and Cytoprotective Activity against Oxidative Stress.

  2018cites this paper
• Synthesis and in vitro evaluation of novel iron chelators based on salicylaldehyde isonicotinoyl hydrazone

  2018cites this paper
• Protocatecheuic Acid Underlies the Antioxidant Activity Exhibited by Illicium Verum Fruit

  2017cites this paper
• 1 Spectroscopic Evidence , Evaluation of Biological 2 Activity and Prediction of the Safety Profile of Fatty 3 Hydroxamic Acids Derived from Olive Oil 4 Triacylglycerides 5

  2017cites this paper
• Mfn2-Mediated Preservation of Mitochondrial Function Contributes to the Protective Effects of BHAPI in Response to Ischemia

  2017cites this paper
• Cardioprotective effects of iron chelator HAPI and ROS-activated boronate prochelator BHAPI against catecholamine-induced oxidative cellular injury.

  2016cites this paper
• Synthesis, characterization and in vitro anticancer evaluations of two novel derivatives of deferasirox iron chelator.

  2016cites this paper
• Characterization of cytoprotective and toxic properties of iron chelator SIH, prochelator BSIH and their degradation products.

  2016cites this paper
• Comparison of various iron chelators and prochelators as protective agents against cardiomyocyte oxidative injury.

  2014cites this paper
• Three H₂O₂ molecules are involved in the "Fenton-like" reaction between Co(H₂O)₆²⁺ and H₂O₂.

  2014cites this paper
• Comparison of various iron chelators used in clinical practice as protecting agents against catecholamine-induced oxidative injury and cardiotoxicity.

  2011cites this paper
• Synthesis and initial in vitro evaluations of novel antioxidant aroylhydrazone iron chelators with increased stability against plasma hydrolysis.

  2011cites this paper
• The effect of pyrophosphate, tripolyphosphate and ATP on the rate of the Fenton reaction.

  2011cites this paper
• Iron chelation with salicylaldehyde isonicotinoyl hydrazone protects against catecholamine autoxidation and cardiotoxicity.

  2011cites this paper
• Comparison of clinically used and experimental iron chelators for protection against oxidative stress-induced cellular injury.

  2010cites this paper
• Skin cell protection against UVA by Sideroxyl, a new antioxidant complementary to sunscreens.

  2010cites this paper
• Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases

  2008cites this paper
• Iron chelating agents for the treatment of iron overload

  2008cites this paper
• Oxidative stress, antioxidants, and assessment of oxidative stress in dogs and cats.

  2007cites this paper
• Duke University Dissertation Template

  2007cites this paper
• Nucleotides and inorganic phosphates as potential antioxidants

  2006cites this paper
• Synthesis of terminally protected (S)-β3-H-DOPA by Arndt–Eistert homologation: an approach to crowned β-peptides

  2005cites this paper
• Ischemia–reperfusion injury pathophysiology, part I

  2004cites this paper
• Iron chelation can modulate UVA‐induced lipid peroxidation and ferritin expression in human reconstructed epidermis

  2004cites this paper
• Ischemia–reperfusion injury: assessment and treatment, part II

  2004cites this paper
• Iron chelator research: past, present, and future.

  2003cites this paper